Cholecystectomy and the risk of colorectal cancer

American Journal of Gastroenterology

Volumn 100, Issue 8, 2005, Pages 1813-1820

  Shao, Theresa ^c   Yang, Yu Xiao ^a,b,c,d  

^a Division of Gastroenterology   (United States)

^b Center for Clinical Epidemiology and Biostatistics   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHOLECYSTECTOMY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; COHORT ANALYSIS; COLON TUMOR; COLORECTAL TUMOR; MIDDLE AGED; RECTUM TUMOR; RISK FACTOR;

ADULT; CHOLECYSTECTOMY; COHORT STUDIES; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECTAL NEOPLASMS; RISK FACTORS;

EID: 25644446874     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.41610.x     Document Type: Article

References (35)

1. Anonymous. Cancer: Number of new cases, 2000, by sex and age. URL: http://www.statistics.gov.uk/ statbase/ssdataset.asp?vlnk=6968; Accessed August 8, 2004. Volume 2004, 2000.
2. Beckingham IJ. ABC of disease of liver, pancreas and biliary system: Gallstone disease. BMJ 2001;322:91-4.
3. Koga S, Kaibara N, Takeda R. Effect of bile acids on 1,2- dimethylhydrazine-induced colon cancer in rats. Cancer 1982;50:543-7.
4. Narisawa T, Magadia NE, Weisburger JH, et al. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst 1974;53:1093-7.
5. Giovannucci E, Colditz GA, Stampfer MJY. A metaanalysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993;105:130-41.
6. Lagergren J, Ye W, Ekbom AY. Intestinal cancer after cholecystectomy: Is bile involved in carcinogenesis? Gastroenterology 2001;121:542-7.
7. Schernhammer ES, Leitzmann MF, Michaud DS, et al. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer 2003;88:79-83.
8. Hollowell J. The General Practise Research Database: Quality of morbidity data. Popul Trends 1997;87:36-40.
9. Garcia Rodriguez LA, Perez Gutthann SY. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998;45:419-25.
10. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997;350:1097-9.
11. Chisholm J. The Read clinical classification. BMJ 1990;300:1092.
12. Schulz EB, Price C, Brown PJ. Symbolic anatomic knowledge representation in the Read Codes version 3: Structure and application. J Am Med Inform Assoc 1997;4:38-48.
13. Perry J. OXMIS problem codes for primary medical care. Oxmis Publications, Oxford, Headington, 1978.
14. Lis Y, Mann RD. The VAMP research multi-purpose database in the U.K. J Clin Epidemiol 1995;48:431-43.
15. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
16. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the general practice research database. Pharmacotherapy 2003;23:686-9.
17. Jick H, Terris BZ, Derby LE, et al. Further validation of information recorded on a general practioner based computerized data source in the United Kingdom. Pharmacoepidemiol Drug Saf 1992;1:347-9.
18. Garcia-Rodriguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001;12:88-93.
19. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004;127:1044-50.
20. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis. Am J Med 1999;106:574-82.
21. Wu K, Willett WC, Fuchs CS, et al. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 2002;94:437-46.
22. La Vecchia C, Negri E, Decarli A, et al. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997;6:1007-10.
23. De Santis A, Attili AF, Ginanni Corradini S, et al. Gallstones and diabetes: A case-control study in a free-living population sample. Hepatology 1997;25:787-90.
24. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989;129:125-37.
25. Malagelada JR, Go VL, Summerskill WH, et al. Bile acid secretion and biliary bile acid composition altered by cholecystectomy. Am J Dig Dis 1973;18:455-9.
26. Hepner GW, Hofmann AF, Malagelada JR, et al. Increased bacterial degradation of bile acids in cholecystectomized patients. Gastroenterology 1974;66:556-64.
27. Brydon WG, Ross AH, Anderson JR, et al. Diet and faecal lipids following cholecystectomy in men. Digestion 1982;25:248-52.
28. Roda E, Aldini R, Mazzella G, et al. Enterohepatic circulation of bile acids after cholecystectomy. Gut 1978;19:640-9.
29. Johansen C, Chow WH, Jorgensen T, et al. Risk of colorectal cancer and other cancers in patients with gall stones. Gut 1996;39:439-43.
30. Kune G. Causes and control of colorectal cancer: A model for cancer prevention. Boston: Kluwer Academic Publishers, 1996:171.
31. Eide TJ. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 1986;38:173-6.
32. Koretz RL. Malignant polyps: Are they sheep in wolves' clothing? Ann Intern Med 1993;118:63-8.
33. Garcia Rodriguez LA, Huerta-Alvarez C. Reduced incidence of colorectal adenoma among long-term users of non-steroidal antiinflammatory drugs: A pooled analysis of published studies and a new population-based study. Epidemiology 2000;11:376-81.
34. Greenland S, Robins JM. Confounding and misclassification. Am J Epidemiol 1985;122:495-506.
35. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164-79.